AFT Pharmaceuticals Income Statement

Financials in millions NZD. Fiscal year is April - March.

Millions NZD. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	236.25	208.02	195.41	156.64	130.31	113.11
Revenue Growth (YoY)	19.01%	6.45%	24.75%	20.20%	15.21%	7.11%
Cost of Revenue	131.05	116.31	107.14	83.66	68.54	64.36
Gross Profit	105.2	91.71	88.27	72.98	61.78	48.74
Selling, General & Admin	70.55	65.05	58.09	49.4	37.99	36.69
Research & Development	10.58	9.77	6.47	3.91	3.62	1.97
Other Operating Expenses	-0.12	-0.75	-0.53	-	-0.23	-0.63
Operating Expenses	81.02	74.07	64.04	53.31	41.39	38.03
Operating Income	24.19	17.65	24.24	19.67	20.39	10.71
Interest Expense	-2.69	-2.82	-3.69	-2.87	-2.44	-3.44
Interest & Investment Income	0.01	0.03	0.07	0.01	0	0
Currency Exchange Gain (Loss)	0.73	0.73	1.11	-3.14	0.64	0.24
Other Non Operating Income (Expenses)	1.08	0.46	0.3	2.13	0.09	0.38
EBT Excluding Unusual Items	23.31	16.03	22.02	15.8	18.69	7.89
Pretax Income	23.31	16.03	22.02	15.8	18.69	7.89
Income Tax Expense	6.73	4.63	6.41	5.15	-1.16	0.11
Earnings From Continuing Operations	16.58	11.4	15.61	10.65	19.85	7.78
Minority Interest in Earnings	0.87	0.56	-	-	-	-
Net Income	17.45	11.96	15.61	10.65	19.85	7.78
Preferred Dividends & Other Adjustments	-	-	-	-	-	0.19
Net Income to Common	17.45	11.96	15.61	10.65	19.85	7.59
Net Income Growth	50.31%	-23.36%	46.51%	-46.32%	155.05%	-38.69%
Shares Outstanding (Basic)	105	105	105	105	105	103
Shares Outstanding (Diluted)	105	105	105	105	105	103
Shares Change (YoY)	-7.83%	-	0.02%	0.16%	1.34%	6.15%
EPS (Basic)	0.17	0.11	0.15	0.10	0.19	0.07
EPS (Diluted)	0.16	0.11	0.15	0.10	0.19	0.07
EPS Growth	59.08%	-26.10%	46.48%	-46.41%	168.07%	-39.61%
Free Cash Flow	9.1	12.9	28.75	11.43	13.82	0.66
Free Cash Flow Per Share	0.09	0.12	0.27	0.11	0.13	0.01
Dividend Per Share	0.018	0.018	0.016	0.011	-	-
Dividend Growth	12.50%	12.50%	45.45%	-	-	-
Gross Margin	44.53%	44.09%	45.17%	46.59%	47.41%	43.09%
Operating Margin	10.24%	8.48%	12.40%	12.56%	15.65%	9.47%
Profit Margin	7.38%	5.75%	7.99%	6.80%	15.23%	6.71%
Free Cash Flow Margin	3.85%	6.20%	14.71%	7.30%	10.61%	0.58%
EBITDA	25.23	18.02	24.63	19.88	20.67	10.97
EBITDA Margin	10.68%	8.66%	12.61%	12.69%	15.86%	9.70%
D&A For EBITDA	1.04	0.37	0.4	0.21	0.28	0.26
EBIT	24.19	17.65	24.24	19.67	20.39	10.71
EBIT Margin	10.24%	8.48%	12.40%	12.56%	15.65%	9.47%
Effective Tax Rate	28.87%	28.90%	29.11%	32.56%	-	1.33%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.